Provided by Tiger Trade Technology Pte. Ltd.

Cullinan Therapeutics

20.59
-0.4100-1.95%
Post-market: 20.590.00000.00%16:10 EDT
Volume:1.09M
Turnover:22.41M
Market Cap:1.33B
PE:-5.94
High:21.34
Open:21.16
Low:20.10
Close:21.00
52wk High:23.19
52wk Low:5.68
Shares:64.35M
Float Shares:48.08M
Volume Ratio:1.32
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4680
EPS(LYR):-3.7236
ROE:-50.30%
ROA:-31.36%
PB:4.12
PE(LYR):-5.53

Loading ...

Cullinan Therapeutics - to Initiate Phase 2 Registrational Study of Cln-049 in Aml in Q3 2026

THOMSON REUTERS
·
Jul 28

Cullinan Therapeutics - Phase 2 Study to Include Dose-Optimization and Single-Arm Cohort at Recommended Dose

THOMSON REUTERS
·
Jul 28

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for Cln-049 and Advances Program to a Potentially Registrational Phase 2 Study in Aml

THOMSON REUTERS
·
Jul 28

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

GlobeNewswire
·
Jul 28

Cullinan Therapeutics management to meet with BTIG

TIPRANKS
·
Jul 15

Cullinan Therapeutics CSO Jennifer Michaelson Sells 8,000 Common Shares for $142,560

Reuters
·
Jul 08

H.C. Wainwright Reaffirms Their Buy Rating on Cullinan Management (CGEM)

TIPRANKS
·
Jun 24

Cullinan Therapeutics shareholders elect two Class III directors at annual meeting

Reuters
·
Jun 17

Cullinan Therapeutics Price Target Maintained With a $37.00/Share by Wedbush

Dow Jones
·
Jun 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Cullinan Therapeutics price target raised to $46 from $33 at Clear Street

TIPRANKS
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner

Reuters
·
Jun 11

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Cullinan Management (CGEM)

TIPRANKS
·
Jun 11

BUZZ-Cullinan rises as early-stage data show remission in autoimmune disease drugs

Reuters
·
Jun 10

Cullinan Therapeutics releases Immunology Day presentation

Reuters
·
Jun 10

Cullinan Therapeutics Reports Early Positive Autoimmune Drug Data, Plans Next Trial Steps

MT Newswires Live
·
Jun 10

Cullinan Therapeutics Highlights Positive Early Autoimmune Trial Data

TIPRANKS
·
Jun 10

Cullinan Therapeutics reports CLN-978, velinotamig data

TIPRANKS
·
Jun 10

Cullinan shares Phase 1 data showing CLN-978 induces remission in difficult-to-treat rheumatoid arthritis patients

Reuters
·
Jun 10